Mid-Afternoon Market Update: Nasdaq Rises 50 Points; Jefferies Shares Drop

Toward the end of trading Wednesday, the Dow traded up 0.05% to 36,269.24 while the NASDAQ rose 0.35% to 15,205.90. The S&P also rose, gaining, 0.26% to 4,725.52.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 63,390,870 cases with around 863,890 deaths. India confirmed a total of at least 36,070,510 cases and 484,650 deaths, while Brazil reported over 22,630,140 COVID-19 cases with 620,280 deaths. In total, there were at least 314,292,710 cases of COVID-19 worldwide with more than 5,522,840 deaths.


Leading and Lagging Sectors


Information technology shares rose 0.6% on Wednesday. Meanwhile, top gainers in the sector included Ebix, Inc. EBIX, up 14% and Innodata Inc. INOD up 9%.


In trading on Wednesday, health care shares fell by 0.4%.


Top Headline


The annual inflation rate in the US increased to 7% in December, notching a fresh high since June 1982, and up from 6.8% in the previous month. Analysts, however, were expecting a 7% inflation rate. The CPI rose 0.50% month-over-month during December.

 

Equities Trading UP


Immix Biopharma, Inc. IMMX shares shot up 26% to $6.83 after the company announced preclinical data of its lead program, IMX-110. The data showed that IMX-110 produced a 50% response rate in first-line-therapy-resistant cancer - soft tissue sarcoma (STS) mouse study, surpassing the STS standard of care doxorubicin’s 0% response rate in the same mouse study.


Shares of Fresh Vine Wine, Inc. VINE got a boost, shooting 44% to $8.41 after the company reported a partnership with CRAVE American Kitchen & Sushi Bar.


Immuron Limited IMRN shares were also up, gaining 43% to $3.65. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing regimen for Travelan more suited for use by the military.


Check out these big movers of the day


Equities Trading DOWN

Koninklijke Philips N.V. PHG shares tumbled 15% to $32.77 after the company provided an update on its financial performance in Q4 2021. Philips hiked the cost of its recall of ventilators and warned earnings would take a big hit from global supply chain shortages.


Shares of Jefferies Financial Group Inc. JEF were down 11% to $36.86 after the company reported worse-than-expected Q4 sales results.


Aclaris Therapeutics, Inc. ACRS was down, falling 14% to $11.04. Providing a R&D update, Aclaris Therapeutics said David Gordon, its chief medical officer left the company, effective Jan. 7. The company also announced update on its two Phase 2 programs that evaluate zunsemetinib in subjects with moderate to severe rheumatoid arthritis and in subjects with moderate to severe hidradenitis suppurative.


Commodities

In commodity news, oil traded up 2% to $82.83, while gold traded up 0.3% to $1,824.20.


Silver traded up 1.5% Wednesday to $23.155 while copper rose 3.8% to $4.5990.


Euro zone

European shares closed higher today. The eurozone’s STOXX 600 gained 0.65%, London’s FTSE 100 rose 0.71%, while Spain’s IBEX 35 Index rose 0.16%. The German DAX gained 0.43%, French CAC 40 climbed 0.75% and Italy’s FTSE MIB Index gained 0.65%.

Wholesale price inflation in Germany slowed to 16.1% in December from a record level of 16.6% in the previous month.


Economics


The annual inflation rate in the US increased to 7% in December, notching a fresh high since June 1982, and up from 6.8% in the previous month. Analysts, however, were expecting a 7% inflation rate. The CPI rose 0.50% month-over-month during December.


US crude-oil inventories dropped 4.6 million barrels last week, the EIA said.


The Federal Open Market Committee released its Beige Book report.


Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Afternoon Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!